CCM
GILD icon

Chiron Capital Management’s Gilead Sciences GILD Stock Holding History

Chiron Capital Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.02M Buy
8,080
+164
+2% +$21.6K 0.92% 33
2026
Q1 		$1.1M Buy
+7,916
New +$1.11M 1.13% 23
2025
Q3 		$1M Sell
9,011
-4
-0% -$455 0.86% 34
2025
Q2 		$1,000K Sell
9,015
-1,408
-14% -$150K 0.87% 37
2025
Q1 		$1.17M Sell
10,423
-12,451
-54% -$1.28M 1.06% 25
2024
Q4 		$2.11M Sell
22,874
-6,003
-21% -$540K 1.99% 6
2024
Q3 		$2.42M Sell
28,877
-8,398
-23% -$641K 2.14% 6
2024
Q2 		$2.56M Buy
37,275
+17,704
+90% +$1.18M 2.44% 3
2024
Q1 		$1.43M Buy
19,571
+6,291
+47% +$484K 1.3% 18
2023
Q4 		$1.08M Sell
13,280
-2,898
-18% -$226K 0.94% 29
2023
Q3 		$1.21M Sell
16,178
-1,500
-8% -$115K 1.04% 24
2023
Q2 		$1.36M Sell
17,678
-5,900
-25% -$471K 1.08% 19
2023
Q1 		$1.96M Sell
23,578
-16,712
-41% -$1.38M 1.36% 9
2022
Q4 		$3.46M Sell
40,290
-61,840
-61% -$4.9M 2.41% 6
2022
Q3 		$6.3M Sell
102,130
-1,048
-1% -$66.1K 4.23% 4
2022
Q2 		$6.38M Buy
103,178
+5,451
+6% +$337K 4.02% 4
2022
Q1 		$5.81M Buy
97,727
+10,053
+11% +$643K 3.66% 4
2021
Q4 		$6.37M Sell
87,674
-7,068
-7% -$487K 4.6% 2
2021
Q3 		$6.62M Sell
94,742
-24,464
-21% -$1.72M 4.83% 2
2021
Q2 		$8.21M Sell
119,206
-4,589
-4% -$306K 6.84% 2
2021
Q1 		$8M Sell
123,795
-3,060
-2% -$197K 6.79% 2
2020
Q4 		$7.39M Sell
126,855
-1,863
-1% -$112K 6.09% 2
2020
Q3 		$8.13M Buy
+128,718
New +$8.93M 6.55% 2

Other funds holding GILD

LMFP
Larry Mathis Financial Planning Phoenix, Arizona $124B AUM
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
CIM
Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return

Chiron Capital Management's GILD Position: Q2 2026 in Review

Chiron Capital Management increased its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, buying an estimated $21.6K and bringing the position to 8,080 shares worth $1.02M. The position accounts for 0.92% of the portfolio, ranked #33.

Chiron Capital Management first reported a position in GILD in Q3 2020 and has held it in 23 quarters since. The position peaked at $8.21M in Q2 2021. 574 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Chiron Capital Management held 8,080 shares of Gilead Sciences worth $1.02M as of Q2 2026.
  • Chiron Capital Management bought 164 Gilead Sciences shares in Q2 2026, an estimated $21.6K.
  • Gilead Sciences made up 0.92% of Chiron Capital Management's portfolio in Q2 2026, its #33 holding.
  • Chiron Capital Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 23 quarters since.
  • Chiron Capital Management's Gilead Sciences position peaked at $8.21M in Q2 2021.
  • 574 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Chiron Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.